2SE.F SEQUANA MEDICAL N.V.

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.5120 EUR
Close of Apr 30, 2026
0.3695 0.7900
Market cap
EUR 40.0M
P/E
-
P/B
9.18x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2024.

Is 2SE.F undervalued?

Graham number

The Graham number of SEQUANA MEDICAL N.V. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SEQUANA MEDICAL N.V. fundamental analysis

No fundamental analysis for SEQUANA MEDICAL N.V. yet.

SEQUANA MEDICAL N.V. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SEQUANA MEDICAL N.V.

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headq…

Full company profile